Related Experiment Video

Updated: Aug 23, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.9K

Brain Metastasis from HER2-Positive Breast Cancer: An Evolving Landscape

Riccardo Soffietti, Alessia Pellerino

    Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
    |October 28, 2022
    PubMed

    Abstract:

    Trastuzumab deruxtecan is a HER2-directed antibody-drug conjugate with ability to cross the blood-tumor barrier and activity on brain metastases. To test the activity of new drugs, patient-derived xenograft models from human brain metastases and phase 0 and window-of-opportunity trials are of utmost importance. See related article by Kabraji et al., p. 174.

    More Related Videos

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
    05:02

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

    Published on: February 4, 2021

    3.4K
    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
    07:43

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

    Published on: February 8, 2017

    27.0K

    Related Experiment Videos

    Last Updated: Aug 23, 2025

    Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
    10:01

    Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

    Published on: August 2, 2022

    6.9K
    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
    05:02

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

    Published on: February 4, 2021

    3.4K
    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
    07:43

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

    Published on: February 8, 2017

    27.0K

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    6.4K
    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    6.4K
    Metastasis02:30

    Metastasis

    5.7K
    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    5.7K

    Articles linked to this work by shared authors, journal, and citation graph.

    Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 Tumors.

    Neurology·2026

    STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

    Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.

    Epilepsia·2025

    Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizures.

    Neuro-oncology advances·2025

    Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

    Neuro-oncology·2025

    STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome.

    Neuro-oncology·2025

    Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Ultrasensitive circulating tumor DNA analysis improves detection of molecular residual disease in locally advanced esophageal cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Efficacy of actinium-225-labeled fully human anti-MUC-16 radioimmunoconjugate against MUC-16-positive ovarian and pancreatic ductal adenocarcinoma xenograft models.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Safety and efficacy of intratumoral MEDI1191, an IL-12 mRNA lipid nanoparticle, plus intravenous durvalumab in patients with advanced solid tumors: a first-in-human study.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

    Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

    Neuro-oncology advances·2026

    Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

    PeerJ·2026

    Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

    ADMET & DMPK·2026

    Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

    MedComm·2026

    Recurrence distance analysis for clinical target volume optimization in glioblastoma.

    Clinical and translational radiation oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us